Annual General Meeting Announcement for Burning Rock Biotech
GUANGZHOU, China – Burning Rock Biotech Limited (NASDAQ: BNR) is excited to announce its forthcoming annual general meeting (AGM), which will take place on December 23, 2025, at 10:30 a.m. local time.
Details of the Meeting
The gathering will occur at the Company’s Shanghai office located at 6/F, Building 10C, Pujiang Smart Plaza, No. 2168 Chenhang Highway, Minhang District, Shanghai. Investors can find the meeting notice and proxy form within the Investors Relations section of our website.
What to Expect at the AGM
During the meeting, key proposals will be presented for consideration by shareholders:
- The appointment of Ernst & Young Hua Ming LLP as the auditor for the fiscal year ending December 31, 2025, is to be ratified. Additionally, the directors will be authorized to set the auditor’s remuneration.
- Re-election of Feng Deng and Licen Lisa Xu as directors of the Company.
- Authorization for each director to take necessary actions to implement the above resolutions at their discretion.
The Board of Directors fully endorses these proposals, urging all shareholders and holders of American depositary shares (ADSs) to vote in favor.
Eligibility to Vote
The deadline for determining shareholders entitled to notice of the AGM is December 1, 2025. This cut-off is set at the close of business on that date (New York time). Holders of the Company’s Class A and Class B ordinary shares, each with a par value of US$0.0002, as of that date, will have rights to attend the AGM and any related postponements.
In order to vote the underlying Class A ordinary shares, holders of ADSs must provide voting instructions to Citibank, N.A., which serves as the depositary for these securities.
Annual Financial Reports and Company Overview
Burning Rock has recently filed its annual report on Form 20-F with the U.S. Securities and Exchange Commission (SEC). This document contains the complete audited financial statements and auditor reports for the year ended December 31, 2024. It is accessible via the Company’s website and the SEC’s site.
About Burning Rock Biotech
Burning Rock Biotech Limited, trading on NASDAQ under the ticker BNR, is dedicated to advancing precision oncology through next-generation sequencing (NGS) technologies. The company’s robust portfolio includes NGS-based therapy selection testing specifically designed for late-stage cancer patients, as well as pioneering work in cancer early detection that's entering clinical validation.
Contact Information
For further inquiries, please reach out to us via email at IR@brbiotech.com.
Frequently Asked Questions
When is the Burning Rock AGM scheduled?
The AGM will be held on December 23, 2025, at 10:30 a.m. local time.
Where will the AGM take place?
The meeting will take place at the Company’s Shanghai office, located at Pujiang Smart Plaza, on Chenhang Highway.
What key proposals will be discussed at the AGM?
Shareholders will vote on the appointment of auditors, the re-election of directors, and authorization for directors to take necessary actions.
Who is eligible to vote at the AGM?
Only those holding Class A and Class B ordinary shares as of December 1, 2025, will be eligible to attend and vote.
How can shareholders access the annual report?
The annual report can be accessed on the Company’s website and on the SEC’s website for interested shareholders.
